_1777370220974_847775619.png&w=48&q=75){kind=small}
Roche, Eli Lilly Alzheimer’s Test Approved
The FDA has approved Roche and Eli Lilly’s blood test, Elecsys pTau217, to help identify signs of Alzheimer’s disease in people aged 55 and older with cognitive decline. The test can be conducted on over 4,500 Roche analyzers in the US, potentially increasing access, with Labcorp and Quest Diagnostics planning to offer it through their networks. It is not meant to be used alone for diagnosis but alongside other clinical information.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)